Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What are Viruses?00:50

What are Viruses?

128.0K
Overview
128.0K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

269
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
269
Hepatic Portal System01:21

Hepatic Portal System

5.7K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

224
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
224
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

562
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
562
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

306
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
306

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designing a novel therapeutic candidate vaccine for HPV16 using immunoinformatics approach: Targeting E6 and E7 epitopes with TLR4 agonist integration.

BioImpacts : BI·2026
Same author

Species Diversity of Mosquitoes (Diptera: Culicidae) in Various Coastal Bioecological Regions of Southern Iran.

Journal of tropical medicine·2026
Same author

Comparative molecular dynamics mapping of metallocarboxypeptidase-peptide interfaces reveals potential hotspots that inspire novel inhibitor design.

Scientific reports·2026
Same author

A structural bioinformatics framework for prioritizing pH-sensitive proteins from 3D structural features.

BMC bioinformatics·2026
Same author

In Vivo Tracking Modalities for Oncolytic Reovirus: Principles, Clinical Applications, and Translational Integration.

Molecular imaging and biology·2026
Same author

Evaluation of nanoliposomal quercetin - paromomycin and clindamycin on cutaneous leishmaniasis skin lesions in BALB/c mice.

Parasitology·2026
Same journal

Engineering a synthetic niche for hADSC preconditioning with PRP, Lp-SN, and resveratrol nanoparticles.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

<i>In-vitro</i> mineralization of borosilicate glasses and accompanying evolution of porous architecture.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Antibacterial and antibiofilm evaluation of biogenic ternary CuO-AgO-MgO nanocomposite against clinical isolates of carbapenem-resistant <i>Klebsiella pneumoniae</i>.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Folate receptor-targeted PEGylated PLGA nanoparticles for the site-specific delivery of hesperidin in epithelial ovarian cancer.

Artificial cells, nanomedicine, and biotechnology·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.3K

Gold nanoparticles and hepatitis B virus.

Babak Negahdari1,2, Mohammad Darvishi3, Ali Asghar Saeedi3

  • 1a Department of Medical Biotechnology, School of Advanced Technologies in Medicine , Tehran University of Medical Sciences , Tehran , Iran.

Artificial Cells, Nanomedicine, and Biotechnology
|March 7, 2019
PubMed
Summary
This summary is machine-generated.

Hepatitis B virus (HBV) infection affects millions globally, increasing liver cancer risk. This review explores gold nanoparticle biosensors for precise HBV detection, aiding early diagnosis and treatment.

Keywords:
Biosensorgold nanoparticlehepatitis B virus

More Related Videos

Gold Nanoparticle Synthesis
13:42

Gold Nanoparticle Synthesis

Published on: July 10, 2021

15.9K
Synthesis and Characterization of Amphiphilic Gold Nanoparticles
10:09

Synthesis and Characterization of Amphiphilic Gold Nanoparticles

Published on: July 2, 2019

18.2K

Related Experiment Videos

Last Updated: Jan 28, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.3K
Gold Nanoparticle Synthesis
13:42

Gold Nanoparticle Synthesis

Published on: July 10, 2021

15.9K
Synthesis and Characterization of Amphiphilic Gold Nanoparticles
10:09

Synthesis and Characterization of Amphiphilic Gold Nanoparticles

Published on: July 2, 2019

18.2K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern, leading to severe liver conditions like cirrhosis and cancer.
  • An estimated 2 billion people have serological evidence of HBV infection, with 360 million suffering from chronic HBV-associated liver disease.
  • Efficient and precise diagnostic methods are crucial for managing HBV and preventing its severe consequences.

Purpose of the Study:

  • To review the current advancements in biosensor technology for Hepatitis B virus detection.
  • To highlight the specific applications and potential of gold nanoparticles in HBV biosensing.
  • To emphasize the importance of biosensors in timely HBV diagnosis and intervention.

Main Methods:

  • Review of existing literature on biosensors and gold nanoparticle applications for HBV detection.
  • Analysis of various biosensor designs and detection mechanisms.
  • Focus on the role of gold nanoparticles in enhancing sensitivity and specificity.

Main Results:

  • Biosensors integrating gold nanoparticles offer a promising approach for sensitive and specific HBV detection.
  • These advanced analytical devices facilitate rapid and accurate diagnosis of HBV infection.
  • Gold nanoparticle-based biosensors contribute to timely intervention strategies for HBV management.

Conclusions:

  • Gold nanoparticle-based biosensors represent a significant technological advancement in the diagnosis of Hepatitis B virus.
  • Their application in detecting HBV is crucial for improving patient outcomes and public health.
  • Continued research in this area is vital for developing even more effective diagnostic tools.